Skip to main content

Arthropathy

0
Pipeline Programs
2
Companies
2
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
1 program
GMK SpheriKAN/A1 trial
Active Trials
NCT05459948Recruiting281Est. May 2035
Stryker
StrykerCA - San Jose
1 program
Restoration Anatomic Acetabular ShellN/A1 trial
Active Trials
NCT05591859Recruiting56Est. Mar 2036

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
StrykerRestoration Anatomic Acetabular Shell
MedactaGMK SpheriKA

Clinical Trials (2)

Total enrollment: 337 patients across 2 trials

NCT05591859StrykerRestoration Anatomic Acetabular Shell

Restoration Anatomic Acetabular Shell Revision Study

Start: Mar 2024Est. completion: Mar 203656 patients
N/ARecruiting
NCT05459948MedactaGMK SpheriKA

The Medacta GMK SpheriKA Post-Marketing Surveillance Study

Start: Jul 2022Est. completion: May 2035281 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 337 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.